CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $0.00, down 50.00% on the session, giving a market capitalisation of $187,697. On trailing twelve-month figures it carries a trailing P/E of -14.93, a net margin of -40.0%. Its beta of -3603.52 implies it has historically moved less than the broad market.
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedicated collection of products for animal companions. The company's principal operations are conducted from Scottsdale, Arizona.
CBD Life Sciences Inc. is most often compared with the following Healthcare names: